Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.29
+0.17 (1.30%)
At close: Mar 9, 2026, 4:00 PM EDT
12.90
-0.39 (-2.93%)
After-hours: Mar 9, 2026, 7:32 PM EDT

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-204.38-97.01-57.51-161.82-122.25
Upgrade
Depreciation & Amortization
8.858.669.2110.119.84
Upgrade
Loss (Gain) From Sale of Assets
---0.01-
Upgrade
Stock-Based Compensation
24.9713.149.817.1916.41
Upgrade
Change in Accounts Receivable
0.1519.66-21.09-30
Upgrade
Change in Accounts Payable
-0.563.42-3.769.35-6.57
Upgrade
Change in Unearned Revenue
-19.83-93.5954.33-3.25-18.46
Upgrade
Change in Other Net Operating Assets
3.31-5.32-10.40.622.04
Upgrade
Operating Cash Flow
-187.49-151.03-19.43-127.78-88.99
Upgrade
Capital Expenditures
-0.72-0.94-1.12-1.36-0.56
Upgrade
Sale of Property, Plant & Equipment
---0.11-
Upgrade
Investing Cash Flow
-0.72-0.94-1.12-1.26-0.56
Upgrade
Issuance of Common Stock
441.3239.81132.5352.9255.83
Upgrade
Other Financing Activities
46.9414.08-14.27-
Upgrade
Financing Cash Flow
488.24253.89132.5367.1955.83
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.14-0.1-0.21-0.21
Upgrade
Net Cash Flow
300.04101.79111.89-62.06-33.93
Upgrade
Free Cash Flow
-188.21-151.96-20.55-129.14-89.55
Upgrade
Free Cash Flow Margin
-440.50%-140.31%-18.13%-3539.11%-218.61%
Upgrade
Free Cash Flow Per Share
-1.12-1.10-0.19-1.64-1.73
Upgrade
Levered Free Cash Flow
-112.55-107.8464.11-67.01-78.24
Upgrade
Unlevered Free Cash Flow
-112.55-107.8464.11-67.01-78.24
Upgrade
Change in Working Capital
-16.94-75.8219.086.727.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.